T. Rowe Price Exchange-Traded Funds, Inc. - TMED
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | History | Added to | 66,660 | 1,928 | 0.0% | 0.0% | 1 | +39,059 | 141.51% | Q1 2026 | May 15, 2026 |
| FLOW TRADERS U.S. LLC | History | Added to | 32,309 | 935 | 0.03% | 0.02% | 2 | +9,121 | 39.34% | Q1 2026 | May 15, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | History | Reduced | 10,035 | 290 | 0.0% | 0.0% | 3 | -1,000 | -9.06% | Q1 2026 | Apr 27, 2026 |
| Essex Financial Services, Inc. | History | No change | 9,100 | 263 | 0.01% | 0.02% | 4 | 0 | 0.0% | Q1 2026 | Apr 24, 2026 |
| UBS Group AG | History | Closed out | 0 | 0 | — | 0.0% | — | -52 | -100.0% | Q1 2026 | May 05, 2026 |